Literature DB >> 22922914

Life-threatening complications following multidose methotrexate for medical management of ectopic pregnancy.

Papa Dasari1, Haritha Sagili.   

Abstract

A 25-year-old primigravida was diagnosed to be suffering from unruptured ectopic pregnancy. The serum β-human chorionic gonadotropin levels were 2851 mIU/l and the ectopic gestational sac was 2.7×2.7 cm without any fetal pole. It was decided to manage her by expectant therapy. But she received medical therapy with multidose methotrexate because of misinterpretation of expectant therapy as medical therapy. She suffered from methotrexate toxicity, which manifested as high-grade fever, vomiting, melena, oral ulcerations, pneumonitis, subconjunctival haemorrhages and skin pigmentation. She developed severe third space fluid collection and shock, which was mistaken for rupture ectopic gestation. Her haematological picture showed severe neutropaenia and thrombocytopaenia which confirmed the clinical picture to be due to methotrexate toxicity. She also developed septicaemia and candidal infection secondary to immunosuppression. She was managed in intensive care unit with ventilatory support, high-dose leucovorin and injection filgastrim. She responded well to the therapy with dramatic recovery in 4 days.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922914      PMCID: PMC4542496          DOI: 10.1136/bcr-03-2012-6023

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Outpatient chemotherapy of unruptured ectopic pregnancy.

Authors:  T G Stovall; F W Ling; J E Buster
Journal:  Fertil Steril       Date:  1989-03       Impact factor: 7.329

2.  Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.

Authors:  Khaled B Soliman; Nisreen M Saleh; Allaa A Omran
Journal:  Saudi Med J       Date:  2006-07       Impact factor: 1.484

3.  Predictors of methotrexate treatment failure in ectopic pregnancy.

Authors:  Serdar Dilbaz; Eray Caliskan; Berna Dilbaz; Ozlem Degirmenci; Ali Haberal
Journal:  J Reprod Med       Date:  2006-02       Impact factor: 0.142

4.  Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study.

Authors:  Emine Seda Guvendag Guven; Serdar Dilbaz; Berna Dilbaz; Burcu Aykan Yildirim; Derya Akdag; Ali Haberal
Journal:  Acta Obstet Gynecol Scand       Date:  2010-07       Impact factor: 3.636

5.  Predictive factors of failure in management of ectopic pregnancy with single-dose methotrexate: a general population-based analysis from the Auvergne Register, France.

Authors:  Benoit Rabischong; Xavier Tran; Aline Abi Sleiman; Demetrio Larraín; Patricia Jaffeux; Bruno Aublet-Cuvelier; Jean-Luc Pouly; Hervé Fernandez
Journal:  Fertil Steril       Date:  2010-09-18       Impact factor: 7.329

6.  Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.

Authors:  Barbara Faganel Kotnik; Iztok Grabnar; Petra Bohanec Grabar; Vita Dolžan; Janez Jazbec
Journal:  Eur J Clin Pharmacol       Date:  2011-04-21       Impact factor: 2.953

7.  Cola beverage and delayed elimination of methotrexate.

Authors:  Raoul Santucci; Dominique Levêque; Raoul Herbrecht
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 8.  Clinical pharmacogenetics of methotrexate.

Authors:  Pasqualina Castaldo; Simona Magi; Annamaria Assunta Nasti; Sara Arcangeli; Vincenzo Lariccia; Nicola Alesi; Massimo Tocchini; Salvatore Amoroso
Journal:  Curr Drug Metab       Date:  2011-03       Impact factor: 3.731

9.  Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases.

Authors:  J D Isaacs; R P McGehee; B D Cowan
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

10.  Diagnosis and management of ectopic pregnancy.

Authors:  Vanitha N Sivalingam; W Colin Duncan; Emma Kirk; Lucy A Shephard; Andrew W Horne
Journal:  J Fam Plann Reprod Health Care       Date:  2011-07-04
View more
  3 in total

1.  Methotrexate Promotes Platelet Apoptosis via JNK-Mediated Mitochondrial Damage: Alleviation by N-Acetylcysteine and N-Acetylcysteine Amide.

Authors:  Manoj Paul; Mahadevappa Hemshekhar; Ram M Thushara; Mahalingam S Sundaram; Somanathapura K NaveenKumar; Shivanna Naveen; Sannaningaiah Devaraja; Kumar Somyajit; Robert West; Siddaiah C Nayaka; Uzma I Zakai; Ganesh Nagaraju; Kanchugarakoppal S Rangappa; Kempaiah Kemparaju; Kesturu S Girish
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

2.  The Management of Heterotopic Pregnancy with Transvaginal Ultrasound-Guided Local Injection of Absolute Ethanol.

Authors:  Conghui Liu; Hong Jiang; Feng Ni; Ying Liu; Wenxiang Zhang; Cuie Feng
Journal:  Gynecol Minim Invasive Ther       Date:  2019-10-24

3.  Multidosing Intramuscular Administration of Methotrexate in Interstitial Pregnancy With Very High Levels of β-hCG: A Case Report and Review of the Literature.

Authors:  Valeria Conti; Giovanni Luciano; Giovanni Pecoraro; Roberto Iovieno; Amelia Filippelli; Maurizio Guida
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.